Unless otherwise noted, speakers have nothing to disclose.

Moderators

Gorav Ailawadi, MD, MBA
Disclosure: Abbott: Consultant Admedus: Advisory Board, Consultant AtriCure,: DSMB member, Research Grant or Support Cryolife, Inc.: Speaker's Bureau Edwards Life Science: Advisory Board, Consultant; Medtronic: Advisory Board, Consultant W. L. Gore & Associates: Consultant)
Joanna Chikwe, MD

Presentations

1. Impact of Hospital Volume of Outcome of Septal Myectomy for Hypertrophic Cardiomyopathy
   Presenter: Kimberly A. Holst, MD
2. Association of patient factors and bioprosthesis size with hemodynamic change over 5 years following RESILIA-based aortic valve replacement
   Presenter: Mubashir A. Mumtaz, MD
   Disclosure: Abbott: Research Grant or Support; AtriCure: Consultant, Research Grant or Support; Boston Scientific: Research Grant or Support; Edwards Life Science: Advisory Board, Consultant, Research Grant or Support Jomdd: Research Grant or Support; Medtronic Inc: Advisory Board, Consultant, Research Grant or Support; Z-Medica: Advisory Board, Consultant, Research Grant or Support
3. Neighborhood Socioeconomic Status Independently Predicts Outcomes After Mitral Valve Surgery: A STS National Database Study
   Presenter: Amit Iyengar, MD, MS
4. Edge-to-edge technique for Mitral Valve Repair compared to Mitral Replacement for Ischemic Mitral Regurgitation
   Presenter: Alex Nantsios, MD
5. Impact of Tricuspid Valve Regurgitation on Late Outcomes of Surgery for Degenerative Mitral Valve Disease
   Presenter: Irsa Hasan, MD